Orionis Biosciences is a life sciences company pioneering technological innovation in genome-scale drug discovery and tunable molecular design of novel therapeutic drug modalities. Our technologies and pipeline include proprietary A-Kine™ biologics and Allo-Glue™ small molecule platforms with broad, innovative applications to the reprogramming of disease states. The company is currently advancing multiple novel immunotherapies for the treatment of cancer.
Company Details
- Employees
- 52
- Address
- 950 Winter St, Waltham,massachusetts 02451,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- orionisbio.com
- Keywords
- Winooski.
- HQ
- Waltham, Massachusetts
Orionis Biosciences Questions
Orionis Biosciences's website is orionisbio.com
Orionis Biosciences's LinkedIn profile is https://www.linkedin.com/company/orionis-biosciences
Orionis Biosciences has
52 employees.
View email and phone details for 52
employees at Orionis Biosciences.
Orionis Biosciences's industry is
Biotechnology Research
Orionis Biosciences's top competitors are
Quibim,
Genentech,
Nest Labs,
Nabla,
Fuse,
Build Collective,
Ledger,
Smartex.ai,
Plumerai,
Arm.
Orionis Biosciences's categories are Biotechnology Research
